Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. - Wikidata - wikimedia - TriplyDB

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.

http://www.wikidata.org/entity/Q37593256

about

Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging Adherence support strategies for exercise interventions in people with mild cognitive impairment and dementia: A systematic review Preoperative Cognitive Performance and Postoperative Delirium Are independently Associated With Future Dementia in Older People Who Have Undergone Cardiac Surgery: A Longitudinal Cohort Study.The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up Compression or expansion of dementia in Germany? An observational study of short-term trends in incidence and death rates of dementia between 2006/07 and 2009/10 based on German health insurance data Awareness, apathy, and depression in Alzheimer's disease and mild cognitive impairment.Enhancing latent cognitive capacity in mild cognitive impairment with gist reasoning training: a pilot study Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging Age-correction of test scores reduces the validity of mild cognitive impairment in predicting progression to dementia Mild cognitive impairment and mild dementia: a clinical perspective.Rates and risk factors for progression to incident dementia vary by age in a population cohort.Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging.Cumulative impact of health deficits, social vulnerabilities, and protective factors on cognitive dynamics in late life: a multistate modeling approach.The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration.Multimorbidity and Risk of Mild Cognitive Impairment.Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects Are We There Yet? Exploring the Impact of Translating Cognitive Tests for Dementia Using Mobile Technology in an Aging Population.A Late Life Risk Index for Severe Cognitive Impairment in Mexico.The New Criteria for Alzheimer's Disease - Implications for Geriatricians Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.Mild cognitive impairment: a concept in evolution Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years The Risk of Incident Mild Cognitive Impairment and Progression to Dementia Considering Mild Cognitive Impairment Subtypes.Factors Related to Noncompliance in Screening and Tracking Mild Cognitive Impairment Patients in a Single Community.The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment.Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline.Characterizing cognitive performance in a large longitudinal study of aging with computerized semantic indices of verbal fluency.Virtual daily living test to screen for mild cognitive impairment using kinematic movement analysis.Predictors of Reversion from Mild Cognitive Impairment to Normal Cognition.The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.Utilization of healthcare services among elderly with cognitive impairment no dementia and influence of depression and anxiety: a longitudinal study.Nursing Home Use Across The Spectrum of Cognitive Decline: Merging Mayo Clinic Study of Aging With CMS MDS Assessments.Mente Activa® Improves Impaired Spatial Memory in Aging Rats.Progression of mild cognitive impairment to dementia in German specialist practices.Stability of Diagnoses of Cognitive Impairment, Not Dementia in a Veterans Affairs Primary Care Population.Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation.

P2860

Q27026362-504B99BE-6722-46C6-A99F-EAEA3B209A7D Q28083708-1D264B0F-FC3D-4E17-B685-A6F6DE3C1137 Q30402834-F4BF4596-CEF6-4A9B-BEB4-DC01DE3D5945 Q30491614-CDD8CF47-4BD3-4C13-94C4-0E87C4B5B600 Q30980369-968606BF-ACAA-438C-9F95-C52816DC91A8 Q31018056-4C69F055-DC0C-4B42-9ECA-5732331D7B7B Q33562180-4262D7B5-4669-4043-929B-C38B566977DF Q33626154-D721BE15-399B-4D64-92C4-AED54DC2BEEF Q34028065-8F562CEB-0F36-4A9A-A78B-B3DF1FC3447A Q34110493-F1905048-8532-4258-A55A-59B2D0CE79B3 Q34289991-25EE1A34-205A-47FE-8628-08F293415155 Q35106548-BC64B1DC-939C-43D9-BA42-EC2F9966A583 Q35400624-1C1A7C91-41EE-468D-8CFE-7B385A741872 Q35687278-2A9CECE3-3858-4BB4-9EE0-273FBFC97C58 Q35833343-5CDAE62B-7141-4E2D-AEE4-0D5FEC1A0290 Q36165338-4670B104-5ED8-43D3-A65A-132D8DF6FD2A Q36528669-66CB1C79-7A2F-4540-8DD4-0B9E7279A223 Q36582235-6E778F7F-E0B4-423C-8A08-697C1C7C749E Q36693969-6287553F-644C-4743-B1A9-215D5AF889B1 Q36855363-11984FD0-96C9-4064-AADA-6E652418FC48 Q37041385-F163E548-D9C8-4E86-B06C-D5FB0BCA8E49 Q37407631-D5AA124F-EA9F-4199-BD8E-47B15B7CEAFE Q37477478-6E24D3D9-543C-460D-AC5C-34412D9F93B9 Q37668090-D3222293-4BB6-4597-8996-AB7B0016FBEF Q37680168-1C4866C4-F7C6-44F8-B748-B665260A8267 Q37695131-2A8B397E-3403-4D60-966D-B71D06064298 Q37706414-4AE38801-B304-4FC1-82FE-848C83F0E4A2 Q38219079-7566A989-4241-4B7D-88CB-A54D988E6C15 Q38377766-BC33A61F-7B9D-489E-8A02-F9040A8AEE7E Q38391886-15EFF3AB-35F4-4724-92C5-1CD11B91C4E7 Q38664772-94B440A3-AE38-496C-BB3E-9097DABF3D7A Q38903030-4C5E5448-424B-458D-B934-3287753815BD Q38927944-7367B387-12C5-4CD4-AD4F-6033FA22E0A6 Q39249384-EE2ABA2E-E63B-4584-A909-FE19098C5E6E Q39902481-D62B689F-6160-4CDB-A846-A15F6F5CFE0D Q40047837-7E2C6C9D-7657-498F-905E-A4C4A2A52DCD Q40494042-8F8FF9CA-F394-4D57-8DA4-23AFF78139F7 Q40531182-D2E30CC8-5C7D-4B1F-803D-E91A4AFF26CD Q40881023-2B9C77B4-911C-43F3-9CB4-46B6EA8E68E6 Q40935892-0447CF13-8D7E-4FB9-91CC-B3A2F23F4230

P2860

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.

http://www.wikidata.org/entity/Q37593256

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Higher risk of progression to ...... nt cases who revert to normal.

@en

Higher risk of progression to ...... nt cases who revert to normal.

@nl

type

label

Higher risk of progression to ...... nt cases who revert to normal.

@en

Higher risk of progression to ...... nt cases who revert to normal.

@nl

prefLabel

Higher risk of progression to ...... nt cases who revert to normal.

@en

Higher risk of progression to ...... nt cases who revert to normal.

@nl

P1433

Q37593256-E4633F4D-50C7-44AB-A079-C4032463F1B0

P1476

Q37593256-338AAF23-4ECF-4A5A-913C-766A5EA1DDD3

P2093

Q37593256-09F044E4-63AE-44F4-8B1A-DB7FCE456810

Q37593256-20CCB166-BEDB-4480-A89D-3B536EED9697

Q37593256-3C576E87-84E4-4661-8DFA-D7BEA9EB20CD

Q37593256-45218851-2AF0-4BB0-A145-4C24FA518794

Q37593256-4E14B844-C579-4E5C-BB24-1DC9C562429D

Q37593256-63280E70-B041-429D-A069-D6D4541DEE64

Q37593256-63B77095-B3B4-4A2C-9576-34F8A43287A2

Q37593256-8524F2DD-34A2-42F3-8CB9-FE29D3646AD5

Q37593256-930266EA-E275-41FA-9939-19D89260CAE8

Q37593256-F4371359-8529-4CC5-B7BB-DEC182F2D507

P2860

Q37593256-01B87473-F143-4C80-BC2B-E482C6DAB039

Q37593256-0D0680EE-AA69-4D17-8BA6-9D24A1D68817

Q37593256-0EDD3441-ADA5-45ED-AD8B-E903A2BA5EA8

Q37593256-11CA7AEB-B594-411C-99D6-84FCB76DD2AB

Q37593256-22D3820C-A72E-4102-9B76-B4A077D2E3CD

Q37593256-2FDDD0BC-4F34-4C78-ABBD-711F9E16490F

Q37593256-317B06CF-CD8E-4E77-A671-64BFD05B5085

Q37593256-32DDD689-6807-478D-886F-C46D306B0701

Q37593256-498C27E1-4521-4A6F-BD20-108048F648A8

Q37593256-4B683CC4-5485-4636-B2FF-EB7A4765248C

P304

Q37593256-577D2134-DA12-4F4E-B29E-F1D0477076F6

P31

Q37593256-7E0E3541-E33A-4068-8FCF-14C1BAF1F522

P356

Q37593256-FD569260-BB05-4228-9A71-F743CD6C20DD

P407

Q37593256-F56A2547-99D5-4E70-BA13-B941411B3001

P433

Q37593256-20950A03-4880-4689-9CC8-2402D3AF7958

P478

Q37593256-A33A3AAB-FF3C-49FC-AD32-45FE4BE1FCD2

P50

Q37593256-132AC423-3CF7-4B8B-926D-AA322F942869

Q37593256-C9E50ACA-AD29-4A24-B0D8-C86A8CA3C021

P577

Q37593256-6D97E150-C145-4D59-8D8E-A8436D197908

P698

Q37593256-45E3E585-A2B4-4237-B1E5-851C6BB9DD53

P921

Q37593256-9FD08351-EECB-4FC2-A0C9-BFBDF5ACCDFC

P932

Q37593256-C802A923-435B-4AA6-BBB9-CB2C5BBF7D90

P356

WNL.0000000000000055

P1433

P1476

Higher risk of progression to ...... nt cases who revert to normal.

@en

P2093

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Eric G Tangalos

http://www.w3.org/2001/XMLSchema#string

Michelle M Mielke

http://www.w3.org/2001/XMLSchema#string

Robert J Ivnik

http://www.w3.org/2001/XMLSchema#string

Rosebud O Roberts

http://www.w3.org/2001/XMLSchema#string

Ruth H Cha

http://www.w3.org/2001/XMLSchema#string

Teresa J H Christianson

http://www.w3.org/2001/XMLSchema#string

V Shane Pankratz

http://www.w3.org/2001/XMLSchema#string

Walter A Rocca

http://www.w3.org/2001/XMLSchema#string

Yonas E Geda

http://www.w3.org/2001/XMLSchema#string

P2860

Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The Clinical Dementia Rating (CDR): current version and scoring rules

Mild cognitive impairment as a diagnostic entity

Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study.

The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Clinical practice. Mild cognitive impairment.

Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging

Mild cognitive impairment: ten years later.

P304

317-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000000055

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Petersen

David S Knopman

P577

2013-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24353333

http://www.w3.org/2001/XMLSchema#string

P921

P932

3929198

http://www.w3.org/2001/XMLSchema#string